Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer

nature.com/articles/s41588-025-02351-7

Abstract
Non-small cell lung cancer (NSCLC) shows variable responses to immunotherapy, highlighting the need for biomarkers to guide patient selection. We applied a spatial multi-omics approach to 234 advanced NSCLC patients treated with programmed death 1-based immunotherapy across…

This story appeared on nature.com, 2025-10-11 15:55:49.403000.
The Entire Business World on a Single Page. Free to Use →